ZHUANA, China — Microbiome therapy is being hailed as a breakthrough in treating a deadly infection that can be fatal for many people, but it also raises concerns about its safety.
The China Academy of Sciences (CAS) on Thursday announced it had developed a new vaccine that could be administered in about 10 minutes.
It is the first time a microbe-based vaccine has been used for treating TB, which is caused by the bacterium Borrelia burgdorferi.
The new vaccine, called ZHUCZ-1, uses the same genetic sequences as the B. burgdorffii bacteria that causes the infection, CAS said in a news release.
Microbes are the building blocks of the human body, and the use of a vaccine targeting microbes could help protect people from TB.
ZHUCC is a bacterial DNA vaccine, a type of vaccine that uses a bacterium’s genetic material to generate the protein DNA.
It is similar to the vaccine currently used to treat other infections, but the vaccine can be administered directly to people without the need for an intravenous injection or a shot.CAS has developed several microbe vaccines for TB, including the microbe vaccine ZM7 and the anti-B.
The new ZHucZ-3 vaccine uses an even more complex DNA structure to deliver the same proteins as the current ZHUF-1 vaccine.ZHUCX-1 has not yet been licensed, but is expected to be available in 2020.
The new ZYUCZ vaccine uses the bacteria’s genome to produce a protein that can then be released to the bloodstream, allowing people to get the vaccine in minutes.